Virco Overview

  • Founded
  • 1994
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Merger of Eq.
  • Financing Rounds
  • 2

Virco General Information

Description

Operator of a pharmaceutical company. The company engages in the discovery and development of drugs for infectious diseases. The company develops HIV/AIDS drugs and anti-invectives for the diseases of high unmet medical need and viral infections.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Pharmaceuticals
Drug Delivery
Acquirer
Primary Office
  • General De Wittelan L11b 4
  • 2800 Mechelen
  • Belgium
+32 015 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Virco Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Virco‘s full profile, request access.

Request a free trial

Virco Executive Team (3)

Name Title Board Seat Contact Info
Carine Claeys Founder
Roger Pomerantz MD President
Rudi Pauwels Ph.D Founder
To view Virco’s complete executive team members history, request access »

Virco Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Virco‘s full profile, request access.

Request a free trial